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THE EFFECT OF DIETARY SUPPLEMENTATION WITH n - 3 POLYUNSATURATED FATTY 
ACIDS ON THE SYNTHESIS OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR BY 
MONONUCLEAR CELLS
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T i n a  S. R o g e r s , P h . D . ,  M a r k  S. K l e m p n e r , M .D ., P e t e r  C .  W e b e r , M .D ., E r n s t  J .  S c h a e f e r , M .D .,
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Abstract We examined whether the synthesis of inter­
leukin-1 or tumor necrosis factor, two cytokines with po­
tent inflammatory activities, is influenced by dietary sup­
plementation with n -3  fatty acids.
Nine healthy volunteers added 18 g of fish-oil concen­
trate per day to their normal Western diet for six weeks. 
We used a radioimmunoassay to measure interleukin-1 
(IL-1/3 and IL-1 a) and tumor necrosis factor produced in 
vitro by stimulated peripheral-blood mononuclear cells. 
With endotoxin as a stimulus, the synthesis of IL-1/3 was 
suppressed from 7.4±0.9 ng per milliliter at base line to 
4.2±0.5 ng per milliliter after six weeks of supplementa­
tion (43 percent decrease; P = 0.048). Ten weeks after 
the end of n -3  supplementation, we observed a further 
decrease to 2.9±0.5 ng per milliliter (61 percent decrease;
IN T E R L E U K IN - 1 and tumor necrosis factor are polypeptide cytokines synthesized by monocytes 
and other cells in response to injury, as well as 
to infectious, inflammatory, or immunologic chal­
lenges. 1' 3 These cytokines induce local inflammatory 
changes and mediate several systemic acute-phase re­
sponses.4,3 Moreover, interleukin-1 and tumor necro­
sis factor often act synergistically —  e.g., on vascular 
endothelium ,'1 insulin production ,7 and the synthesis 
of metabolites of arachidonic acid .8
The n —3 (also called omega-3) fatty acids are poly-
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P = 0.005). The production of IL-1 a and tumor necrosis 
factor responded in a similar manner. Twenty weeks after 
the end of supplementation, the production of IL-1 /3, IL-1 a, 
and tumor necrosis factor had returned to the presupple­
ment level. The decreased production of interleukin-1 and 
tumor necrosis factor was accompanied by a decreased 
ratio of arachidonic acid to eicosapentaenoic acid in the 
membrane phospholipids of mononuclear cells.
We conclude that the synthesis of IL-1/3, IL-1 a, and tu­
mor necrosis factor can be suppressed by dietary supple­
mentation with long-chain n -3  fatty acids. The reported 
antiinflammatory effect of these n -3  fatty acids may be 
mediated in part by their inhibitory effect on the production 
of interleukin-1 and tumor necrosis factor. (N Engl J Med 
1989; 320:265-71.)
unsaturated fatty acids in which the last double bond 
is located between the third and fourth carbon atom 
from the methyl end of the fatty acid chain. These 
fatty acids are scarce in a normal Western diet but 
make up an appreciable part of the fat intake in diets 
rich in cold-water fish and seal meat.'' Epidemiologic 
studies in populations of coastal Eskimo,10,1! Jap a ­
nese,1“ and D utch 1 * subjects have shown that a high 
intake of n — 3 fatty acids correlates with a low inci­
dence of cardiovascular and inflammatory diseases 
such as asthma and Type I diabetes mellitus. 11 The 
modification of the fatty acid composition of cell 
membranes and the formation of eicosanoids by di­
etary supplementation with n — 3 fatty acids have sub­
sequently been shown in hum an beings . 14,10 In  
healthy volunteerslb and in patients with asthma , 17 
n —3 dietary supplementation results in decreased 
neutrophil chemotaxis and inhibited generation of 
leukotriene B4 by neutrophils and monocytes. In  clini­
cal studies, dietary supplementation with n —3 fatty 
acids has led to improvements in patients with rheu­
matoid arthritis18 and in patients with psoriasis. 14 
Prospective studies in animals fed n —3 fatty acids sup­
port these clinical observations.20'23
Since interleukin- 1 and tumor necrosis factor are 
the principal polypeptide mediators of inflammation,
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reduced production of these cytokines may contribute 
to the amelioration of inflammatory symptoms in pa­
tients receiving n — 3 supplementation. In this study 
we investigated the effects of dietary supplementa­
tion with n — 3 fatty acids on the synthesis of the cyto­
kines interleukin- 1 and tumor necrosis factor in nor­
mal subjects.
M e t h o d s  
Subjects and Study Design
The study was approved by the Human Investigative Review 
Committee of the New England Medical Center Hospitals. Nine 
healthy male volunteers entered the study after giving informed 
consent (average age, 28 years; range, 21 to 39). The initial study 
group consisted of six volunteers, and a second group of three 
volunteers entered the study six months after tlu* first group. Roth 
groups were studied in the same fashion. Since the results were 
similar in the two groups, the data for the nine subjects are pooled in 
this report.
For six weeks, the subjects added 18 g of marine lipid concentrate 
(six capsules of MaxEPA three times per day, kindly provided by 
R.P. Scherer. Troy, Mich.) to their otherwise unchanged diets. By 
gas chromatography, the n — 3 fatty acid content of I g of the lipid 
concentrate was shown to consist of 153 mg of eicosapentaenoic 
acid and 103 g of docosahexaenoic acid. The subjects were free of 
disease and refrained from taking any medications during the course 
of the study. Before supplementation, the subjects' mean caloric 
intake ranged from 2 0 0 0  to 3000 kcal per day. Six to 1 0  percent 
of the calories (mean, 28 g) were highly unsaturated fatty acids, 
but less than 1 percent were n —3 fatty acids. During supplemen­
tation, the intake of highlv unsaturated fattv acids increased from
28 to 34 g.
The production of interleukin-1 and tumor necrosis factor by 
stimulated-blood mononuclear cells in vitro was assessed during 
four phases of the study: before the start of n — 3 supplementation, 
during the 6 th week of supplementation, and during the 1 0 th and 
2 0 th weeks after the end of supplementation (the latter two phases 
being washout periods). To ascertain reproducibility, blood sam­
ples were obtained on three different days, two to three days apart, 
during each of the four phases of the study. The mean of these three 
replicate determinations was calculated and used for further analy­
sis. We were unable to make measurements during the 20th week of 
the washout period in one of the six subjects in the first group of 
volunteers.
During the first six weeks of the study, when the second group of 
volunteers was taking the supplement, we also studied a control 
group of four healthy male volunteers who did not receive the sup­
plement. In vitro production of interleukin- 1  and of tumor necrosis 
factor was assessed twice, during week 1 and week 7. Blood sam­
pling was performed on two different days during the first and 
seventh week, and the mean was calculated.
Stimulation of Mononuclear Cells in Vitro
Venous blood was drawn into syringes pretreated with heparin 
(20 U per milliliter), and the mononuclear-cell fraction was ob­
tained by Ficoll-Hypaque centrifugation. At the same time a sam­
ple of blood was obtained without heparin in order to prepare heat- 
inactivated (56°C, 40 minutes) serum. The mononuclear cells were 
washed twice in 0.15 M sodium chloride, slides were prepared by 
cytocentrifugation, and 1 0 0  cell-differential counts were performed 
in a blinded fashion on coded slides. RPMI-1640 culture medium 
(Whittaker M.A. Bioproducts, Walkersville, Md.), supplemented 
with 2 niM levo-glutamine, 1 0 0  U of penicillin per milliliter, and 
1 0 0  /zg of streptomycin per milliliter, was subjected to ultrafiltra­
tion to remove endotoxins, as described elsewhere. 2 4  The mononu­
clear cells were suspended at a concentration of 5X 1 0 *’ cells per 
milliliter in RPM I medium with 2 percent heat-inactivated autolo­
gous serum, and 100 ¡±\ was divided into aliquots in 96-well flat- 
bottomed microtiter plates. An equal volume of either serum-free 
RPM I or RPM I containing various stimulants was added. The cells
were stimulated with endotoxin (lipopolysaccharide Escherichia coli 
055:B5, Sigma, St. Louis) at I and 10 ng per milliliter, phyto­
hemagglutinin (Difco, Detroit) at 3 /xg per milliliter, or heat- 
killed Staphylococcus epidermidis, opsonized with 2.5 percent fresh 
autologous serum, at 20 bacteria per mononuclear cell. After incu­
bation for 24 hours at 37°C in 5 percent carbon dioxide, the supcrna- 
tants were removed from some wells and frozen at — 70°C for the 
determination of prostaglandin E. The microtiter plates were frozen 
until the end of the study. At that time all the plates for each 
donor were simultaneously thawed and exposed to two more 
freeze-thaw cycles to complete cell lysis. The contents of triplicate 
wells, consisting of cell lysates and supernatants, were pooled 
and refrozen for determinations of interleukin- 1 and tumor necro­
sis factor.
Determinations of lnterleukin-1 and Tumor Necrosis Factor
The total synthesis of cytokines (i.e., cell-associated cytokines 
plus secreted cytokines) was determined by radioimmunoassays for 
two forms of human interleukin-1 (IL-l/3and IL-la) and for tumor 
necrosis factor. Details on the specificity and sensitivity of each 
radioimmunoassay have been reported elsewhere. 2  >i/ Each radio­
immunoassay was specific for the respective cytokine. For a given 
stimulus, samples from all four study phases for each donor were 
assayed in a single radioimmunoassay for each cytokine.
Prostaglandin Determination
Prostaglandin E^ content in mononuclear-cell supernatants was 
determined by direct competitive radioimmunoassay. Anti-pros­
taglandin Ej serum, kindly provided by Dr. William Campbell 
(University of Texas Health Science Center at Dallas), has a cross­
reactivity of 14 percent with prostaglandin E| and of 2.7 percent 
with prostaglandin E.,a. Prostaglandin E_> standard was provided by 
Dr. John Pike (Upjohn, Kalamazoo, Mich.). [’H]Prostaglandin E_, 
was purchased from Amersham (Arlington Heights, 111.). The assay 
does not distinguish between prostaglandin E2  and prostaglandin 
E {. The assay sensitivity for prostaglandin E 2  is 50 pg per milliliter.
Neutrophil Chemotaxis
Polymorphonuclear neutrophils were isolated from the pellet 
after Ficoll-Hypaque density-gradient centrifugation, and their 
chemotactic response to synthetic leukotriene B.} (Sigma) was as- 
saved with use of blind well chambers, as described elsewhere. 2 , 1
#
I'he migration distance of polymorphonuclear neutrophils was 
measured with the leading-front method. Each condition (buffer 
alone or with leukotriene B., added at 10~!l, 10-H, 10-7, and 10~fl M) 
was assayed in triplicate. Polymorphonuclear neutrophils from 
healthy subjects not receiving n — 3 fatty acid supplementation were 
assayed in parallel (same-day control). The results are expressed as 
percent increases over spontaneous migration in buffer.
Fatty Acid Analyses
For the measurement of plasma fatty acids, 18 ml of blood was 
drawn into EDTA-coatcd tubes and centrifuged for 20 minutes at 
800Xg. The plasma was removed and frozen at — 70°C1 until ana­
lyzed. Lipids were extracted and methylated, as described else­
where. For the determination of the fatty acid composition of 
mononuclear cells, cells obtained on three different days during 
each of the four study phases were pooled, for a total of 4 .5 x 1 0 '’ 
mononuclear cells per subject. The lysates of these cells were centri­
fuged at 1 0 0 ,0 0 0 Xg and extracted, and the phospholipids were puri­
fied and transmethylated as described elsewhere. 1 0  The fatty acid 
methyl esters were analyzed by gas-liquid chromatography on an 
HP-5980 gas chromatograph . 2 9 , 3 0  The amounts of individual fatty 
acids were expressed as relative percentages, with total fatty acids 
set as 1 0 0  percent.
Statistical Analysis
The results are expressed as means ±SEM. Two-tailed Student’s 
t-tests for paired samples were performed on a Clinfo software sys­
tem (Bolt, Beranek and Newman, Cambridge, Mass.) After Bonier-
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roni’s adjustment for multiple t-tests in one group, P values less 
than 0.05 were considered to be significant.
R e s u l t s  
Plasma and Mononuclear-Cell Lipids
The volunteers reported no untoward effects of in­
gesting the fish-oil concentrate. Compliance was con­
firmed by a significant increase in plasma levels of 
eicosapentaenoic acid, from 0.4±0.‘2 mg per deciliter 
at base line to 17.3±0.7 mg per deciliter during 
the sixth week of supplementation (P<0.001). Plas­
ma eicosapentaenoic acid was still slightly increased 
(1.1 ±0.3 mg per deciliter; P =  0.035) 10 weeks after 
cessation of the supplement and returned to the pre- 
supplementation level (0 .6 ± 0.2 mg per deciliter) 
within 20 weeks after cessation of the supplement. 
Triglyceride levels were reduced from the presupple­
mentation level (1.03±0.02 mmol per liter [91 ±20 
mg per deciliter]) to 0.66±0.12 mmol per liter (59± 1 1 
mg per deciliter) after six weeks of n — 3 supple­
mentation (P<0.040). They returned to the presup­
plementation levels at 10 weeks (1.09±0.23 mmol 
per liter [97± 2 1  mg per deciliter]) and 20 weeks 
(1.04±0.14 mmol per liter [93± 13 mg per deciliter]) 
after cessation of the supplement. Cholesterol levels 
and leukocyte and platelet counts did not change 
significantly. These data confirm previous findings on 
the effects of similar doses of n —3 fat tv acids on 
plasma levels of fatty acids30 and on triglyceride 
levels.31
The composition of mononuclear-cell phospholipid 
fatty acids was determined in the mononuclear-cell 
membranes of five randomly chosen volunteers during 
the four study phases (Table 1 ). After six weeks of 
n — 3 fatty acid supplementation, there was a signifi­
cant increase in eicosapentaenoic acid, from 0.7 per­
cent before the supplement to 3.8 percent (P = 0.02), 
with a concomitant decrease of arachidonic acid, from 
13.8 percent before the supplement to 8.6 percent 
(P =  0.04). Ten weeks after the end of supplemen­
tation, there was still a trend to increased eicosa-
Table 1. Fatty Acid Composition of Mononuclear-Cell Membranes
as a Percentage of Total Fatty Acid Content.*
Fatty B efore  n - 3 A fter n - 3 Time a f t e r  E n d  o f
Ac id S u p p le m e n t S u pplem en t n - 3  S u pplem en t
10 w e e k s 20 WEEKS
mean percentage ±SEM
A A (n —6) 13.8± 1.3 8 .6±0.7t 9 .5± l.8$ 13.8±2.6t
RPA (n-3) 0 .7 ± 0 .1 3.8±0.7§ 1.0±0.3$ 0.6±0. I t
DHA (n-3) 2.3±0.2 3.3±0.4+ 2.0± 0.4t 2 .5±0.7t
AA/EPA ratio 20.9±2.2 2.4±0.21l 12.0±2. Ill 23.9±4.3+
‘ Mononuclear cells were obtained from live subjects receiving dietary supplementation ol 
n 3 fatty acids. AA denotes arachidonic acid. EPA eicosapentaenoic acid, and DHA docosa- 
liexaenoic acid.
* Decreased from presupplement levels (P<0.()4). 
No significant change from presupplement levels. 
^Increased from presupplement levels (P<0.03). 
’ Decreased from presupplement levels (P<0.(K)3). 
Decreased from presupplement levels (P<0.03).
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Figure 1. In Vitro Synthesis of IL-1 [3 by Mononuclear Cells of Nine 
Subjects, Stimulated with Endotoxin (1 ng per Milliliter) during
Dietary Supplementation.
Each point represents the average of three determinations on 
three different days, two to three days apart, in each subject. The 
inset shows the synthesis of IL-1 (3 by mononuclear cells stimulat­
ed with the same dose of endotoxin in four control subjects with­
out dietary supplementation, during an interval of seven weeks.
pentaenoic acid and decreased arachidonic acid 
concentrations, and the ratio of arachidonic acid 
to eicosapentaenoic acid remained significantly sup­
pressed at a value of 12.0, as compared with 20.9 
before supplementation (P = 0.02) and 23.9 at week 
20 after cessation of the supplement. Twenty weeks 
after the end ol' supplementation, both eicosapentae­
noic acid and arachidonic acid had returned to the 
presupplementation levels.
Effect of n -3  Fatty Acid Supplementation on the
Production of lnterleukin-1 and Tumor Necrosis Factor
Figure I shows the individual values for the produc­
tion of IL-l/3 at each phase of the study. The produc­
tion ol' IL-l/3 in vitro was decreased after six weeks of 
n —3 supplementation. At that time, mononuclear 
cells stimulated by I ng of endotoxin per milliliter 
produced only 4.2 ng of IL-l/3 per milliliter, as com­
pared with the presupplementation level of 7.4 ng per 
milliliter (43 percent decrease; P = 0.048; Fig. I). Ten 
weeks after the end of n — 3 supplementation, lL-l/3 
production had decreased further, to 2.9 ng per millili­
ter (61 percent decrease; P =  0.005).
The production of IL-1/3 returned to the presupple­
mentation level 20 weeks after the end of supplemen-
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tation (7.5 ng per milliliter; P not significant). During 
an interval of six weeks, IL-1 (3 production in a control 
group of four subjects (who were not taking the sup­
plement) did not change significantly (Fig. 1, inset). 
Figure 2 shows the mean values for each subject, ex­
pressed as the percent change from values before sup­
plementation. Induction of IL-1 ¡3 by a higher dose of 
endotoxin (10 ng per milliliter) produced similar re­
sults (data not shown).
Endotoxin-induced concentrations of IL-1 a and tu­
mor necrosis factor decreased in a similar pattern (Fig. 
2A). IL-1 a  production fell from 16.0 ng per milliliter 
at base line to 10.9 ng per milliliter (32 percent de­
crease; P not significant) after 6 weeks of n —3 supple­
mentation, and to 9.7 ng per milliliter (39 percent 
decrease; P =  0.022) 10 weeks after the end of supple­
mentation. The production of tumor necrosis factor 
dropped from 8.5 ng per milliliter at base line to 6.6 ng
n-3 Supplement
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Figure 2. Synthesis of IL-1 (Solid Bars), IL-1« (Hatched Bars), 
and Tumor Necrosis Factor (TNF; Open Bars) by Mononuclear 
Cells Stimulated with 1 ng of Endotoxin per Milliliter (Panel A) or 
3 /xg of Phytohemagglutinin per Milliliter (Panel B).
The concentration of total cytokine (i.e., cell-associated plus se­
creted) was determined by radioimmunoassay. Concentrations 
are presented as percentages of presupplementation levels. With 
endotoxin stimulation, the concentrations were 7.4 ng of IL-1 /3 per 
milliliter, 16.0 ng of IL-1 a per milliliter, and 8.5 ng of tumor necro­
sis factor per milliliter. With phytohemagglutinin stimulation, the 
concentrations were 3.0 ng of IL-1 >3 per milliliter and 14.0 ng of 
IL-1 a per milliliter. Each bar represents the mean of 27 determina­
tions (nine donors assayed on three days each). The error bars 
denote the SEM for the nine donors. An asterisk denotes a signifi­
cant difference from the level before dietary n -3  supplementation
(at PC0.05).
Table 2. IL-1/3, IL-1 a, and Tumor Necrosis Factor Induced in 
Mononuclear Cells by Heat-Killed S. epidermidis *
B efore  n - 3  
S u pplem en t
A fter n - 3  T im e  after E n d  of  
S u p p lem en t  n - 3  S u p p lem en t
to w e e k s 20 WEEKS
mean ±SEM
IL-lß (ng/ml) 
IL-1 a  (ng/ml) 
TNF (ng/ml)
31.8 ±4.5 
5.8± 1.1 
37.9±3.4
26 .3± 5 .1 25.2±3.5 
4.5± 1.0 5.9± 1.1 
32.1 ±5.5 35.5±3.9
25.6±2.6
5.2±0.8
32.5±3.6
♦Mononuclear cells were obtained from nine subjects receiving dietary supplementation of 
n - 3  fatty acids.
per milliliter (22 percent decrease; P not significant) 
after 6 weeks of the supplement and to 5.1 ng per 
milliliter (40 percent decrease; P =  0.008) 10 weeks 
after the end of supplementation. Twenty weeks after 
the end of supplementation, the production of these 
cytokines had also returned to the presupplementation 
levels.
The proportion of monocytes in the mononuclear­
cell population (after Ficoll-Hypacjue separation) was
19.1 ±4.4 percent and did not change significantly 
after 6 weeks of the supplement or at 10 weeks after 
the end of supplementation.
The levels of interleukin- 1 and tumor necrosis fac­
tor induced by the phagocytosis of heat-killed S. epi­
dermidis were measured (Table 2). This phagocytic 
stimulus was four times more potent than the high 
dose of endotoxin ( 10  ng per milliliter) in inducing the 
production of IL -1 ¡3 and tumor necrosis factor. These 
levels showed slight, insignificant decreases during 
week 6 of the n — 3 supplement and at 10 weeks after 
the end of supplementation.
To assess the possible role of altered interleukin- 1 
production in mediating the eilect of n —3 fatty acids 
during an immunologic challenge, we also measured 
the induction of IL-1 ¡3 and IL-1 a  by phytohemagglu­
tinin in the same cell population (Fig. 2B). After six 
weeks of n — 3 supplementation, the production of 
IL-1 a  had decreased significantly, from 14.0 to 12.0 
ng per milliliter (14 percent decrease; P =  0.044). 
During the 10th week after the end of supplementa­
tion, however, both cytokines were significantly re­
duced: IL -1 (3 by 53 percent (from 3.0 to 1.4 ng per 
milliliter; P =  0.003), and IL-1 a  by 37 percent (from
14.2 to 9.0 ng per milliliter; P =  0.0001).
We studied a control group during the same interval 
that we studied the second group of volunteers in the 
first two phases of n — 3 supplementation. Although 
endotoxin stimulation of the mononuclear cells from 
these control subjects produced lower amounts ol 
IL-1/3 (Fig. 1, inset), the production of this cytokine at 
week 7 did not significantly change (102±16 percent 
of the levels produced at week 1 ). The levels ol 
IL- la  and tumor necrosis factor were 116± 10 and 
90±6 percent, respectively, at week 7. At that time, 
cytokine production induced by S. epidennidis was 
110± 8 percent of the levels at week 1 for IL-1/3,
1 00± 13 percent for IL -1 a, and 1 1 1  ± 2 percent for tu-
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mor necrosis factor. 'There was no significant change 
in the in vitro production of interleukin- 1 and tumor 
necrosis factor in volunteers receiving no dietary sup­
plementation during an interval of six weeks.
Prostaglandin Synthesis
In the initial group of six volunteers, prostaglandin 
E-2 release was measured in the supernatant of mono­
nuclear cells stimulated by .S’, epidennidis (Fig. 3). Pros­
taglandin E-j release decreased from 612 pg per millili­
ter at base line to 302 pg per milliliter after 6 weeks of 
supplementation (51 percent decrease; P = 0.008), to 
423 pg per milliliter (P not significant) after 10 weeks 
of supplementation, and to 812 pg per milliliter (P not 
significant) after 20 weeks of supplementation. After 
cessation of the supplement there was no significant 
change in prostaglandin E2 release from the presup­
plement level.
Neutrophil Chemotaxis
Random migration of polymorphonuclear neutro­
phils in both the study and control subjects was un­
changed at all times (data not shown). The chemotac- 
(ic responses of polymorphonuclear neutrophils after 
six weeks of n — 3 supplementation were suppressed at 
all four concentrations of leukotriene B4. Figure 4 
shows that chemotaxis to 10-/ M  leukotriene B.(, 
which elicited the highest response, was 83±8.2 per­
cent (mean of percent increase over random migra­
tion) before the n —3 supplement, 62±5.0 percent after 
6 weeks of the supplement, and 79 12.5 percent 10 
weeks after cessation of the supplement. The suppres­
sion of chemotaxis after six weeks of supplementation 
was significant as compared with the presupplement 
control (P =  0.038) and with the control group as­
sayed on the same day (94± 1 1.9 percent; P =  0.041). 
1'his is in agreement with the findings of Lee et a l . 10 
on decreased neutrophil chemotaxis in healthy vol­
unteers whose diet was supplemented with n — 3 
fatty acids.
D i s c u s s i o n
O ur results show that dietary supplementation with 
n-3 fatty acids reduces the amount of inducible pro­
duction of interleukin- 1 and tumor necrosis factor bv 
mononuclear cells in vitro. The reduced production of 
IL-1/3, IL-lct, and tumor necrosis factor may contrib­
ute to the decreased inflammatory responses reported 
in patients receiving n — 3 supplementation.^
We studied the production of interleukin- 1 and 
tumor necrosis factor bv total mononuclear cells rath-
J
n than by enriched monocytes. Since monocytes, 
I cells,32 B cells,33 and large granular lymphocytes34 
synthesize interleukin- 1 and tumor necrosis factor, we 
believe that the.response of the whole cell popula­
tion is biologically more relevant than that of en­
riched subpopulations. Although we studied periph­
eral mononuclear cells as an accessible source, it is 
probable that dietary n — 3 fatty acids also decrease the 
production of interleukin- 1 and tumor necrosis factor
n -3 n -3 after End 
of n - 3
after End 
of n -3
Figure 3. Secretion of Prostaglandin E (PGE) by Mononuclear 
Cells Stimulated with Opsonized, Heat-Killed S. epidermidis
(20 Organisms per Cell).
Prostaglandin E was measured in the supernatant by radioimmu­
noassay. Each bar represents the mean of 18 determinations (six 
donors assayed on three different days each). The error bars 
denote the SEM for the six donors. The asterisk denotes a signifi­
cant difference from the level before n -3  supplementation
(at P<0.05).
by other types of cells, such as synovial cells, alveolar 
macrophages, and mesangial,35 vascular,36 and skin 
cells.37 Since we measured total interleukin- 1 and tu­
mor necrosis factor (i.e., both cell-associated and se­
creted), our results demonstrate that n — 3 fatty acids 
affect the synthesis rather than the release of these
J
cytokines.
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Figure 4. Chemotactic Response of Neutrophils to
Leukotriene B4.
The migration of neutrophils in response to 10"7 M leukotriene B4 
is expressed as a percentage of increase over random migration. 
The bars represent the mean ±SEM for nine subjects in the study 
group (hatched bars, n -3  supplement) and for five control sub­
jects (open bars, no dietary supplement). Ten weeks after the end 
of supplementation, five of the nine subjects in the study group 
were studied. The asterisk denotes a significant difference from
the level before n -3  supplement (at P<0.05).
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interleukin- 1 and tumor necrosis factor by mononucle-
4
ar cells for as long as 10 weeks after cessation of 
the n — 3 supplement, accompanied by persistent fatty 
acid changes in these cells, was a striking phenomenon 
observed in both sets of volunteers. Since mono­
cytes in the circulation had been formed in the bone
4
marrow only a few days e a r l i e r , i t  is possible that 
our findings reflect the recycling of n — 3 fatty acids 
from a slow-turnover compartment of fatty acids. 
The ratio of arachidonic acid to eicosapentaenoic 
acid, which was maximally suppressed immediately 
after n — 3 supplementation, reflects the measurement 
of the total phospholipid fatty acid pool. This does not 
allow conclusions about intracellular compartments 
or phospholipid subclasses. Thus, we cannot exclude 
the altered fatty acid composition of a critical com­
partment at 10 weeks after the end of supplementa­
tion, when the suppression of cytokine production was 
maximal.
We observed functional changes in cytokine pro­
duction as late as 10 weeks after n — 3 supplementation 
was discontinued; other investigators have also ob­
served the l o n g  persistence of biochemical changes 
associated with n — 3 fatty acid supplementation .30 In 
a clinical trial in patients with rheumatoid arthritis, 18 
leukotriene B4 generation in neutrophils remained be­
low base-line levels for as Ion«' as 18 weeks after n — 3
O
fatty acid supplementation was stopped. Concomi­
tantly, in the crossover design of that study, the treat­
ment group still had clinical improvement when it 
entered the placebo phase after a washout period of 
four weeks. The prolonged effects of dietary n — 3 fatty 
acid supplementation on the production of interleu­
kin-1 and tumor necrosis factor has implications for 
the design of future clinical trials. A maximal efiect on 
mononuclear-cell cytokine production may be reached 
slowly during supplementation and may persist for at 
least 10 weeks after cessation of the supplement. This 
prolonged effcct should be taken into account in the 
planning of washout periods, particularly in crossover 
designs.
The mechanism underlying the suppression of the 
synthesis of interleukin- 1 and tumor necrosis factor 
after dietary supplementation with n — 3 fatty acids 
remains unknown. However, alterations in the type of 
arachidonic acid metabolites produced during stimu­
lation of the mononuclear cells may explain in part the 
decreased production of these two cytokines.39,40 The 
n — 3 fatty acids induce changes in both cyclooxyge- 
nase and lipoxygenase products. One possible mecha­
nism may be decreased 5-lipoxygenase metabolites 
such as leukotriene B . j . ln' ll> Adding exogenous leu­
kotriene B.j to human mononuclear cells enhances 
endotoxin-stimulated production of interleukin-1 . 11 
Conversely, inhibitors of 5-lipoxygenase reduce the 
production of interleukin-1 .42>4:i Supplementation 
with the same n — 3 fatty acid preparation in the same 
dosage and during the same time as in the present 
study decreased monocyte leukotriene B.} production 
by 58 percent in healthy volunteers.lf{ Thus, a possible 
mechanism for decreased interleukin- 1 production is
decreased synthesis of leukotriene B.j and generation 
of the biologically less active metabolite leukotriene B5 
from eicosapentaenoic acid.
Although the clinical importance of our observa­
tions is uncertain, our findings may explain in part 
the antiinflammatory ell'ects of n — 3 fatty acids. 18-21 
Whether other unsaturated fatty acids have similarJ
effects remains to be determined.
Wc arc indebted to Scott F. Orencolc, Steven D. Sisson, Judith R. 
McNamara, and Ingrid Weiss for technical assistance, to Deirdre 
G. Rees and Dr. Junxian Gong lor fatty acid analysis, to Nick 
Papathanasopoulos for advice in the statistical analysis, to Hannes 
Eisele for assistance in data transmission, and to Judith Bollinger- 
Gruber and Drs. Jeffrey A. Gelfand, David V. Ives, Burton 1).• J  J
Clark, Laurie Miller, and Reinhard Lorenz for helpful discussions.
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ASSOCIATION OF ASTHMA WITH SERUM IgE LEVELS AND SKIN-TEST REACTIVITY 
TO ALLERGENS
B e n j a m i n  B u r r o w s , M . D . ,  F e r n a n d o  D .  M a r t i n e z , M . D . ,  M a r i l y n  H a l o n e n , Ph.D.,
R o b e r t  A. B a r b e e , M . D . ,  a n d  M a r t h a  G. C l i n e , M.S.
Abstract We investigated the association of self-report- 
ed asthma or allergic rhinitis with serum IgE levels 
and skin-test reactivity to allergens in 2657 subjects 
in a general-population study. Regardless of the sub­
jects’ status with respect to atopy or their age group, the 
prevalence of asthma was closely related to the serum IgE 
level standardized for age and sex (P<0.0001), and no 
asthma was present in the 177 subjects with the lowest 
IgE levels for their age and sex (>1.46 SD below the 
mean). The log odds ratio increased linearly with the se­
rum IgE level after we controlled for possible confounders 
and the degree of reactivity to skin tests. In contrast, aller-
I
T is generally accepted that there are both allergic 
and nonallergic forms of asthma, and the distinc­
tion is usually based on the presence or absence of 
allergy skin-test reactivity to one or more aeroal- 
lergens considered capable of inducing the disease. 
Since Rackemann introduced the terms in 1918,1 asth­
ma that can be shown to be related to hypersensitivity 
to a foreign substance has been described as “extrin­
sic” ; otherwise, the disease has been classified as 
'intrinsic.”
After IshizakaJ and Johansson3 and their colleagues
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gic rhinitis appeared to be associated primarily with skin- 
test reactions to common aeroaliergens, independently of 
the serum IgE level.
We conclude that asthma is almost always associated 
with some type of IgE-related reaction and therefore has 
an allergic basis, although not all the allergic stimuli that 
cause asthma appear to have been included in the battery 
of common aeroaliergens we used to assess atopic sta­
tus. These findings challenge the concept that there are 
basic differences between so-called allergic (“extrinsic”) 
and nonallergic (“intrinsic”) forms of asthma. (N Engl J 
Med 1989; 320:271-7.)
identified immunoglobulin E (IgE) as the antibody 
responsible for the immediate type of immune re­
sponse, a number of authors noted marked elevations 
of IgE in young patients with asthma,4,0 and some 
have attempted to distinguish extrinsic from intrinsic 
disease on the basis of the presence or absence of an 
elevated serum concentration of IgE .(j Regardless of 
the specific criteria, however, extrinsic asthma ap­
pears to be the predominant form of the disease 
among children and young adults, and intrinsic asth­
ma is considered to be more common among older 
subjects.
These widely accepted concepts, based largely on 
clinical observations, fail to take into account the rela­
tions of both allergy skin-test reactivity (hereafter 
called atopy) and serum IgE levels to age in the gener­
al population. Both tend to decrease with advancing
